Honors Program Peer-reviewed Publications

The name that appears in capital letters graduated with Special Honors from the Honors Program

Rivera, M. I.; HINOJOSA, L. M.; Hill, B. A.; Lau, S; Monks, T. J. "Metabolism and toxicity of 2-bromo-(diglutathion-S-yl)-hydroquinone and 2-bromo-3-(glutathion-S-yl) hydroquinone in the in situ perfused rat kidney" Drug Metabol. Disp. 1994, 22(4), 503-510.

KEITH, M. S.; Stanislav, S. W.; Wesnes,K. A. "Validity of a cognitive computerized assessment system in brain-injured patients" Brain Injury 1998, 12(12), 1037-1043.

Williams, R. O.; ROGERS, T. L.; Liu, J. "Study of solubility of steroids in hydrofluoroalkane propellants" Drug Dev. Indust. Pharm. 1999, 25(12), 1227-1234.

Williams, R.O.; BROWN, J., Lui, J. "Influence of micronization method on the performance of a suspension trimcinolone acetonide pressurized metered–dose inhaler formulation" Pharm. Dev. Tech. 1999, 4(2), 167-179.

Chen, T.; Friedman, K.A.; LEI, I.; Heller, A. "In situ assembled mass-transport controlling micromembranes and their application in implanted amperometric glucose sensors" Anal. Chem. 2000, 72(16), 3757-3763.

WRIGHT, R.; Crismon, M. L. "Comparison of three a priori methods and one empirical method in predicting dosage requirements" Am. J. Health-Syst. Pharm. 2000, 57(18), 1698-1702.

PATEL, N. C.; Crismon, M. L.; Rush, A. J.; Frances, A. “Practioner versus medication-expert opinion on psychiatric pharmacotherapy of mentally retarded patients with mental disorders” Am. J. Health-Syst. Pharm. 2001, 58, 1824-1829.

Williams, R. O.; PATEL, A.; Barron, M. K.; ROGERS, T. L. “Investigation of some commercially available spacer devices for the delivery of glucocorticoid steroids from a pMDI” Drug Devel. Indust. Pharm. 2001, 27(5), 401-412.

Kerwin, S. M.; CHEN, G.; Kern, J. T.; Thomas, P. W. “Perylene Diimide G-quadruplex DNA binding selectivity is mediated by ligand aggregation” Bioorg. Med. Chem. Lett. 2002, 12, 447-450.

Williams, R. O.; Reynolds, T. D.; Cabelka, V.; SYKORA, M. A.; Mahaguna, V. “Investigation of excipient type and level on drug release from controlled release tablets containing HPMC” Pharm. Dev. Technol. 2002, 7(2), 181-193.

CHUANG, W.-C.; Crismon, M. L. “Evaluation of a schizophrenia medication algorithm in a state hospital” Am. J. Health-Syst. Pharm. 2003, 60, 1459-1467.

CALA, S.; Crismon, M. L.; Baumgartner, J. “A survey of herbal use in children with attention-deficit-hyperactivity disorder or depression” Pharmacotherapy 2003, 23(2), 222-230.